EWTX
Edgewise Therapeutics, Inc. · Healthcare
General Counsel John R Moore sold $86K of Edgewise Therapeutics, Inc.
Sold$85,921
$9.31Price
9,232Shares
−75%Stake
What EWTX did after the filing
- The stock from Fri, Aug 5 close, $10.67
- −16.4%
- S&P 500, same days
- −5.6%
Measured over 30 trading days, to the Sep 19 close.
Traded Wed, Aug 3. Filed Fri, Aug 5, 12:12 PM ET, during the session. Returns use the Aug 5 close and the Sep 19 close. Not investment advice.